Predicting progression-free survival after systemic therapy in advanced head and neck cancer: Bayesian regression and model development.

Elife · 2022 · PMC9815805 · PMID 36562609

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

failed to reach significanceno p-value reported

While exosome EGFR-HER3 heterodimer failed to reach significance in our risk signature, it was close as depicted in the Kaplan-Meier curve from Figure 3C shown below.

also in 4,113 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.